NCT01031186View on ClinicalTrials.gov

First Time in Human Study

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

November 23, 2009

Primary Completion Date

April 7, 2010

Study Completion Date

April 7, 2010

Conditions

Depressive Disorder and Anxiety Disorders

Interventions

DRUG

GSK356278

GSK356278

DRUG

PLACEBO

PLACEBO

Trial Locations (1)

2031

GSK Investigational Site, Randwick

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01031186 - First Time in Human Study | Biotech Hunter | Biotech Hunter